Company intelligence / Profile preview

MySugarWatch DuoPack

St. Ouen, Jersey

Ownership: Private
Development stage: Other

Overview

MySugarWatch DuoPack is a commercialization and distribution partner for Nemaura Medical’s sugarBEAT non‑invasive continuous glucose monitor, bundling CGM sensors and transmitters as “DuoPacks” with prescription medicines (including insulin) for people with type 2 diabetes under a global commercial contract signed in 2021.

Therapeutic areas: Endocrinology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Nemaura Medical (global commercial contract for sugarBEAT CGM devices and sensors to be supplied as MySugarWatch-branded DuoPacks with prescription medicines, with global rights for this bundled use)

Beyond the preview

Go deeper on MySugarWatch DuoPack.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MySugarWatch DuoPack.

Explore the full profile